Toxicological evaluation of oral exposure to isoniazid: behavioral, biochemical, and histopathological assessments in rats
Isoniazid (INH), being the first-line drug used as an anti-tuberculosis drug, is known to be associated with physiological deteriorations including hepatic and neurologic disturbances. This study was aimed at biochemical and behavioral characterization of toxic manifestations of isoniazid treatment...
Saved in:
Published in: | Drug and chemical toxicology (New York, N.Y. 1978) Vol. 45; no. 6; pp. 2594 - 2600 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Taylor & Francis
02-11-2022
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Isoniazid (INH), being the first-line drug used as an anti-tuberculosis drug, is known to be associated with physiological deteriorations including hepatic and neurologic disturbances. This study was aimed at biochemical and behavioral characterization of toxic manifestations of isoniazid treatment in Wistar rats. Experimental animals were divided into four groups. Each group consists of six animals including the control group (saline solution), I25 group (25 mg/kg of INH), I50 group (50 mg/kg of INH), and I100 group (100 mg/kg of INH). Animals received daily INH for 30 days. Isoniazid is known to be associated with hepatotoxicity; it's among the most common causes of drug-induced toxicities. For this reason assays for aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), and lactate dehydrogenase (LDH) were performed to assess liver toxicity. Moreover, behavioral study, renal, and lipid parameters were also assessed in addition to histological features of the liver and brain. Significant differences in all studied parameters were seen especially in the I100 group and a marked increase in liver enzymes activities, such as AST and ALT was observed. In another hand, there were no major clinical signs in treated animals, except fatigue and anxiety in the I100 group. On the other hand, the histological findings showed potential liver and brain injury which was evidenced by degenerative changes, infiltration, and hepatocyte necrosis, in addition to the appearance of many pyramidales cells in the gyrus. The current study findings suggest that INH interacts with multiple biochemical pathways in the body what comes up by behavioral changes and liver disturbances in animals caused by INH toxicity. |
---|---|
AbstractList | Isoniazid (INH), being the first-line drug used as an anti-tuberculosis drug, is known to be associated with physiological deteriorations including hepatic and neurologic disturbances. This study was aimed at biochemical and behavioral characterization of toxic manifestations of isoniazid treatment in Wistar rats. Experimental animals were divided into four groups. Each group consists of six animals including the control group (saline solution), I25 group (25 mg/kg of INH), I50 group (50 mg/kg of INH), and I100 group (100 mg/kg of INH). Animals received daily INH for 30 days. Isoniazid is known to be associated with hepatotoxicity; it's among the most common causes of drug-induced toxicities. For this reason assays for aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), and lactate dehydrogenase (LDH) were performed to assess liver toxicity. Moreover, behavioral study, renal, and lipid parameters were also assessed in addition to histological features of the liver and brain. Significant differences in all studied parameters were seen especially in the I100 group and a marked increase in liver enzymes activities, such as AST and ALT was observed. In another hand, there were no major clinical signs in treated animals, except fatigue and anxiety in the I100 group. On the other hand, the histological findings showed potential liver and brain injury which was evidenced by degenerative changes, infiltration, and hepatocyte necrosis, in addition to the appearance of many pyramidales cells in the gyrus. The current study findings suggest that INH interacts with multiple biochemical pathways in the body what comes up by behavioral changes and liver disturbances in animals caused by INH toxicity. |
Author | Dahmani, Israa Gaies, Emna Ben Ali, Ridha El Fekih, Moncef Chedly, Achraf Ben Said, Dorra Elmay, Michelle-Véronique El Aidli, Sihem Bassem, Hammami |
Author_xml | – sequence: 1 givenname: Dorra surname: Ben Said fullname: Ben Said, Dorra organization: Research Unit n° 17/ES/12, Faculty of Medicine, University of Tunis El Manar – sequence: 2 givenname: Israa surname: Dahmani fullname: Dahmani, Israa organization: Research Unit n° 17/ES/12, Faculty of Medicine, University of Tunis El Manar – sequence: 3 givenname: Ridha surname: Ben Ali fullname: Ben Ali, Ridha organization: Research Unit n° 17/ES/13, Laboratory of Histology and Embryology, Faculty of Medicine of Tunis, University of Tunis El Manar – sequence: 4 givenname: Hammami surname: Bassem fullname: Bassem, Hammami organization: UR05/08-08, LR99/ES/11, Department of Biochemistry, Rabta Hospital, University of Tunis El Manar – sequence: 5 givenname: Moncef surname: El Fekih fullname: El Fekih, Moncef organization: UR05/08-08, LR99/ES/11, Department of Biochemistry, Rabta Hospital, University of Tunis El Manar – sequence: 6 givenname: Achraf surname: Chedly fullname: Chedly, Achraf organization: Laboratory of Anatomy and Pathology, Habib Thameur Hospital – sequence: 7 givenname: Michelle-Véronique surname: Elmay fullname: Elmay, Michelle-Véronique organization: Research Unit n° 17/ES/13, Laboratory of Histology and Embryology, Faculty of Medicine of Tunis, University of Tunis El Manar – sequence: 8 givenname: Emna surname: Gaies fullname: Gaies, Emna organization: Research Unit n° 17/ES/12, Faculty of Medicine, University of Tunis El Manar – sequence: 9 givenname: Sihem surname: El Aidli fullname: El Aidli, Sihem organization: Research Unit n° 17/ES/12, Faculty of Medicine, University of Tunis El Manar |
BookMark | eNp9kE1P3DAQQC1EJRboT6jkYw9ksR07m_REhfiSkLjQszVx7K6rxLP1eCnw69loKUdOI828eYd3zA4TJs_YNymWUrTiXEjdCqPNUgkll7JbdUJ1B2whjTJVs7sessXMVDN0xI6J_gghVWfqBXt9xOfocMTf0cHI_ROMWygRE8fAMc-r5w3SNntekEfCFOE1Dj9479fwFGfijPcR3dpPs-GMQxr4OlLBDZT1hxiIPNHkUyEeE89Q6JR9CTCS__o-T9iv66vHy9vq_uHm7vLnfeVUJ0vVKN8YcH27UqIXvZRCD1pLB2BaUE7q4FbQDo1xQeuulbqvG90F47qhVhJCfcK-772bjH-3noqdIjk_jpA8bskqszJ1q5pa7VCzR11GouyD3eQ4QX6xUti5tf3f2s6t7Xvr3d_F_i-mgHmCf5jHwRZ4GTGHDMlFsvXnijfnP4ou |
Cites_doi | 10.1016/j.ijpharm.2005.09.033 10.22159/ajpcr.2017.v10i6.11971 10.1016/j.biopha.2016.11.119 10.1007/s11010-005-5778-x 10.1016/j.tox.2009.08.006 10.1080/17843286.1999.11754234 10.1016/S0213-005X(11)70011-8 10.1038/nbt.2838 10.2174/138920007782798216 10.1038/clpt.2010.151 10.1007/s00228-002-0465-2 10.1016/0735-6757(93)90001-R 10.1038/1811199a0 10.2165/00044011-200323070-00007 10.1016/j.ejmech.2011.08.010 10.1016/j.jhep.2013.05.030 10.12980/APJTB.4.2014APJTB-2014-0236 10.1038/npp.2010.71 10.1073/pnas.81.7.2247 10.1002/(SICI)1522-7146(1996)11:3<139::AID-JBT6>3.0.CO;2-L 10.3109/01480545.2015.1092039 |
ContentType | Journal Article |
Copyright | 2021 Informa UK Limited, trading as Taylor & Francis Group 2021 |
Copyright_xml | – notice: 2021 Informa UK Limited, trading as Taylor & Francis Group 2021 |
DBID | AAYXX CITATION 7X8 |
DOI | 10.1080/01480545.2021.1979029 |
DatabaseName | CrossRef MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1525-6014 |
EndPage | 2600 |
ExternalDocumentID | 10_1080_01480545_2021_1979029 1979029 |
Genre | Research Articles |
GroupedDBID | --- 00X 03L 0BK 0R~ 29G 36B 4.4 5GY AAJNR AALUX AAMIU AAPUL AAPXX AAQRR ABBKH ABDBF ABEIZ ABLKL ABPTK ABUPF ACENM ACFUF ACGEJ ACGFS ACLSK ADCVX ADFCX ADRBQ ADXPE AECIN AENEX AEOZL AEYQI AFKVX AFWLO AGDLA AGFJD AGRBW AGYJP AIJEM AIRBT AJWEG AKBVH ALIIL ALMA_UNASSIGNED_HOLDINGS ALQZU BABNJ BLEHA BOHLJ CCCUG CS3 DKSSO DTRLO DU5 EAP EBS EDH ESX F5P HZ~ J.N KRBQP KSSTO KUULJ KWAYT KYCEM LJTGL M4Z O9- RNANH RVRKI TFDNU TFL TFW UHWXJ V1S ~1N AAYXX ABJNI ABLIJ ABXYU ACIEZ ALYBC CITATION EBC EBD EMB EMK EMOBN EPL H13 MK0 SV3 TBQAZ TDBHL TERGH TUROJ TUS 7X8 |
ID | FETCH-LOGICAL-c291t-62e65acb8720b0b1104d441caa58a2c14fc7a8d65cf449814b3649f5c9d321af3 |
ISSN | 0148-0545 |
IngestDate | Fri Oct 25 10:33:14 EDT 2024 Thu Nov 21 22:55:31 EST 2024 Tue Jun 13 19:27:00 EDT 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c291t-62e65acb8720b0b1104d441caa58a2c14fc7a8d65cf449814b3649f5c9d321af3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PQID | 2575382632 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | informaworld_taylorfrancis_310_1080_01480545_2021_1979029 proquest_miscellaneous_2575382632 crossref_primary_10_1080_01480545_2021_1979029 |
PublicationCentury | 2000 |
PublicationDate | 2022-11-02 |
PublicationDateYYYYMMDD | 2022-11-02 |
PublicationDate_xml | – month: 11 year: 2022 text: 2022-11-02 day: 02 |
PublicationDecade | 2020 |
PublicationTitle | Drug and chemical toxicology (New York, N.Y. 1978) |
PublicationYear | 2022 |
Publisher | Taylor & Francis |
Publisher_xml | – name: Taylor & Francis |
References | Eyuboglu T. (CIT0007) 2013; 55 CIT0012 Romero J.A. (CIT0020) 1998; 57 Tai D.Y. (CIT0025) 1996; 37 CIT0014 CIT0013 CIT0016 CIT0015 CIT0018 CIT0017 CIT0019 CIT0021 CIT0001 EldebssTaha M.A. (CIT0006) 2014; 3 CIT0023 CIT0022 Khoharo H.K. (CIT0010) 2009; 21 Violina T.A. (CIT0027) 2019 CIT0003 CIT0002 CIT0024 CIT0005 CIT0004 CIT0026 CIT0028 CIT0009 CIT0008 |
References_xml | – ident: CIT0023 doi: 10.1016/j.ijpharm.2005.09.033 – ident: CIT0021 doi: 10.22159/ajpcr.2017.v10i6.11971 – ident: CIT0002 doi: 10.1016/j.biopha.2016.11.119 – ident: CIT0005 doi: 10.1007/s11010-005-5778-x – ident: CIT0028 doi: 10.1016/j.tox.2009.08.006 – ident: CIT0026 doi: 10.1080/17843286.1999.11754234 – ident: CIT0016 doi: 10.1016/S0213-005X(11)70011-8 – ident: CIT0022 doi: 10.1038/nbt.2838 – ident: CIT0018 doi: 10.2174/138920007782798216 – volume: 21 start-page: 178 issue: 2 year: 2009 ident: CIT0010 publication-title: Journal of Ayub Medical College contributor: fullname: Khoharo H.K. – volume: 55 start-page: 328 issue: 3 year: 2013 ident: CIT0007 publication-title: Turkish Journal of Pediatrics contributor: fullname: Eyuboglu T. – ident: CIT0014 doi: 10.1038/clpt.2010.151 – ident: CIT0009 doi: 10.1007/s00228-002-0465-2 – ident: CIT0015 doi: 10.1016/0735-6757(93)90001-R – ident: CIT0004 doi: 10.1038/1811199a0 – volume: 57 start-page: 749 issue: 4 year: 1998 ident: CIT0020 publication-title: American Family Physician contributor: fullname: Romero J.A. – volume: 37 start-page: 222 issue: 2 year: 1996 ident: CIT0025 publication-title: Singapore Medical Journal contributor: fullname: Tai D.Y. – start-page: 1 year: 2019 ident: CIT0027 publication-title: Drug and Chemical Toxicology contributor: fullname: Violina T.A. – ident: CIT0012 doi: 10.2165/00044011-200323070-00007 – ident: CIT0017 doi: 10.1016/j.ejmech.2011.08.010 – ident: CIT0003 doi: 10.1016/j.jhep.2013.05.030 – ident: CIT0001 doi: 10.12980/APJTB.4.2014APJTB-2014-0236 – ident: CIT0019 doi: 10.1038/npp.2010.71 – ident: CIT0008 doi: 10.1073/pnas.81.7.2247 – ident: CIT0024 doi: 10.1002/(SICI)1522-7146(1996)11:3<139::AID-JBT6>3.0.CO;2-L – ident: CIT0013 doi: 10.3109/01480545.2015.1092039 – volume: 3 start-page: 356 year: 2014 ident: CIT0006 publication-title: Asian Journal of Biochemical and Pharmaceutical Research contributor: fullname: EldebssTaha M.A. |
SSID | ssj0012953 |
Score | 2.3287134 |
Snippet | Isoniazid (INH), being the first-line drug used as an anti-tuberculosis drug, is known to be associated with physiological deteriorations including hepatic and... |
SourceID | proquest crossref informaworld |
SourceType | Aggregation Database Publisher |
StartPage | 2594 |
SubjectTerms | behavioral disruption drug toxicity Isoniozid liver injury neurologic disturbances |
Title | Toxicological evaluation of oral exposure to isoniazid: behavioral, biochemical, and histopathological assessments in rats |
URI | https://www.tandfonline.com/doi/abs/10.1080/01480545.2021.1979029 https://search.proquest.com/docview/2575382632 |
Volume | 45 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9swEBdp-zIYY-s21n2hwuhL42DL8tfesiaje1gpWwZ7M7ItUz_ULnYCTf_63Vmy5SyBroy-mCDLktD9cjqddL8j5JNvJ7nt5b7FJQssniagB3mQWFEA648UgSvb_CnnP4OL3-FszuejUUd6ZMoeVdJQBrLGyNkHSLtvFArgN8gcniB1eP6b3KvbIu01miHzRquwjcaXtzcVugXR6sSrRIW4K9pEzyZiH-c9KTCXVksm0N3wbLmJMYVx37zoeT3ba7WApmZo7c7qlYqA7FqCPvXo1rvSAJ06sNsc-Ca-SFA-olA3k6u67peQmbi6VsmoTr81tRDDD6Yq4PtHkV2Zchxoi3z01IvrYujsgH0yOnDN1nixlXfkL9coGKDqjFxqdc48C7acfKjvdY1iW3l7Kt-yNgSQun_nIqNvZUJ_2N0ExulMYH4iW8_PJn-3frNHDhjoQlDFB9Oz-cX3_qiLRYoqtRt-F2aGBPC7utgwoDbodbfMidZGWjwnz_Tmhk4VKl-QkSwPycmlYkdfj-nCBPs1Y3pCLw1v-vqQPFUuZKoi416Suw0oUwNlWuUUYUo7KNNlRXsof6YGyGM6gPGYAhTpFojpAMS0KCmC-BX59XW-ODu3dKoQK2WRs7R8Jn1PpEkYMDuxE7BpeQaGfiqEFwqWOjxPAxFmvpfmnEehwxPX51HupVHmMkfk7muyX1alfEOoJ1gooF4GKy_PpBSOzKCiHUYc9g4ePyKTbv7jG8UIEzsd0a4WWIwCi7XAjkg0lFK8bEGcK_zG7j3fHncijUHv42GeKGW1amJYasFWwWwLb_-j_XfkifmbvSf7y3olP5C9Jlt91Dj9A-xqz4s |
link.rule.ids | 315,782,786,27933,27934,59868,60657 |
linkProvider | Taylor & Francis |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrZ1La9wwEICHZnNoILTNi6bPCZSc1oktyw_1FtINW5osgW4gNyHLEvhiL_UuZPfXR-PHbkMpPaR3SdjSaGY00nwD8CX2M-tHNva4YYnHdeb0IE8yTyTO_hiVhKapnzL-mUzu028jwuSsc2HoWSWdoW0Limh0NW1uCkb3T-LOKQrmXI3IHe9YcBaIRPhMbME2scbTAWxfXI4mN-u7BCZaFiWFzqhXn8fzt4GeWKgn_NI_9HVjhK5e_4_PfwOvOhcUL1qZ2YMXptyH09uWYb0c4nSTklUP8RRvN3Tr5T7stoE-bPOXDmA1rR4K3atQ3NDDsbJI6f9oHmYVxSFxXiG9XSrUqsi_4gYQMMSsoMJdDblgiO7HsMEgU7Xk9cBqjRCtsSjRCW59CHdXo-nl2OsKOniaiWDuxczEkdJZmjA_8zPnefDcuWNaqShVTAfc6kSleRxpy7lIA56FMRc20iIPWaBseASDsirNW8BIsVS5drnTjzw3RgUmdw39VHDn4UX8GM76RZSzltshgx6H2s2_pPmX3fwfg_h9qeW8CZjYtrqJDP_R96SXC-l2J125qNJUi1o6hegsCjHx3z1j_M_wcjy9uZbX3yc_3sMOowwMimyzDzCY_1qYj7BV54tPneA_Ass0AZA |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrZ1La9wwEIBFHlAKIUnTljyaZAolp3Viy5Jt9bYku6S0XRa6hd6ErAf4Yi_1LiT59dH4sdsQSg7tXRK2NJoZjTTfEPIpCXMXcpcEzNI0YDr3epCleSBSb3-sSmPb1E-5_ZFOfmU3I8TkDPtcGHxWiWdo14IiGl2Nm3tuXP8i7gqDYN7T4P50R6PLSKQipGKTbHtfnPvz1_bwejT5vrpKoKJFUWLkDHv1aTx_G-iJgXqCL32mrhsbNN77D1-_T3Y7BxSGrcS8IRu2PCAX05ZgfT-A2Tohqx7ABUzXbOv7A7LThvmgzV56Sx5m1V2hewUKa3Y4VA4w-R_s3bzCKCQsKsCXS4V6KMxnWOMBBpAXWLar4RYMwP8XNBBkrJW8GlitAKI1FCV4sa3fkZ_j0ez6NujKOQSaimgRJNQmXOk8S2mYh7n3O5jxzphWimeK6og5narMJFw7xkQWsTxOmHBcCxPTSLn4Pdkqq9IeEuCKZsq3M147MmOtiqzxDcNMMO_fcXZELvs1lPOW2iGjHobazb_E-Zfd_B8R8edKy0UTLnFtbRMZv9D3Yy8W0u9NvHBRpa2WtfTq0NsTJOIf_8P45-TV9GYsv32ZfD0hrymmX2BYm34gW4vfS3tKNmuzPOvE_hGYwgA0 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Toxicological+evaluation+of+oral+exposure+to+isoniazid%3A+behavioral%2C+biochemical%2C+and+histopathological+assessments+in+rats&rft.jtitle=Drug+and+chemical+toxicology+%28New+York%2C+N.Y.+1978%29&rft.au=Ben+Said%2C+Dorra&rft.au=Dahmani%2C+Israa&rft.au=Ben+Ali%2C+Ridha&rft.au=Bassem%2C+Hammami&rft.date=2022-11-02&rft.pub=Taylor+%26+Francis&rft.issn=0148-0545&rft.eissn=1525-6014&rft.volume=45&rft.issue=6&rft.spage=2594&rft.epage=2600&rft_id=info:doi/10.1080%2F01480545.2021.1979029&rft.externalDocID=1979029 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0148-0545&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0148-0545&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0148-0545&client=summon |